There has been recent media coverage concerning a rare atypical femoral fracture that may be a side effect of denosumab (Prolia), an osteoporosis medication manufactured by Amgen. Osteoporosis Canada’s Scientific […]

Treatments Did you know? Osteoporosis leads to fragility fractures. These are broken bones that happen from a minor injury but that have major consequences such as pain, disability and sometimes […]

PRESS RELEASE TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention. Dr. Famida Jiwa, President & CEO, Osteoporosis […]

A UNIQUE WAY TO CREATE AWARENESS ABOUT BONE HEALTH Attendees of Toronto Fashion Week saw something unusual on the catwalk this year: a line of innovative fashions incorporating bubble wrap! […]

Zoe Bond, Dana Li and Rebecca Wills Diabetes and Fracture Risk Diabetes mellitus, commonly known as diabetes, is a condition that affects the hormone insulin, resulting in high blood sugar […]

Calcium Supplementation When Your Doctor Advises You To Take A Calcium Supplement If you find it difficult to obtain the recommended amounts of calcium through diet alone, your physician may […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, Dr. Emma Billington and Dr. Wendy Ward. Recommendations from Osteoporosis Canada Rapid Response Team. LeBoff and colleagues (1) […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Osteoporosis can have a significant impact on our physical and emotional well-being including how broken bones and the diagnosis of osteoporosis can affect our sexuality and intimacy. Sexuality can be […]